Hiscox (LON:HSX - Get Free Report) had its price objective raised by investment analysts at JPMorgan Chase & Co. from GBX 1,600 to GBX 1,800 in a research report issued to clients and investors on Tuesday,Digital Look reports. The firm presently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price objective suggests a potential upside of 17.19% from the stock's current price.
Several other equities analysts also recently commented on HSX. Jefferies Financial Group upped their price target on shares of Hiscox from GBX 1,068 to GBX 1,148 and gave the company an "underperform" rating in a research note on Thursday, March 5th. The Goldman Sachs Group upped their price target on shares of Hiscox from GBX 1,560 to GBX 1,713 and gave the company a "buy" rating in a research note on Wednesday, January 21st. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of GBX 1,516.83.
View Our Latest Report on Hiscox
Hiscox Price Performance
Shares of HSX opened at GBX 1,536 on Tuesday. The firm has a market capitalization of £4.96 billion, a PE ratio of 8.78, a PEG ratio of -2.30 and a beta of 0.36. The company's 50-day moving average is GBX 1,533.86 and its 200-day moving average is GBX 1,448.28. Hiscox has a fifty-two week low of GBX 1,130 and a fifty-two week high of GBX 1,624.
About Hiscox
(
Get Free Report)
Hiscox is a global, specialty insurer, listed on the London Stock Exchange and headquartered in Bermuda. We have grown from
our roots as a niche Lloyd's of London underwriter into a diversified international insurance group operating across direct‑to‑consumer, broker and partner‑distributed retail insurance; large and complex commercial insurance; reinsurance and insurance‑linked strategies.
We currently employ over 3,000 people worldwide across 13 countries and 31 offices. We have a distinctive brand, energised and ambitious teams, a strong balance sheet, and plenty of room to grow in each of our chosen markets and lines of business.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hiscox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hiscox wasn't on the list.
While Hiscox currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.